A Preliminary Study on the Relationship between Platelet Serotonin Transporter Functionality, Depression, and Fatigue in Patients with Untreated Chronic Hepatitis C
- PMID: 24778869
- PMCID: PMC3978905
- DOI: 10.1155/2014/821381
A Preliminary Study on the Relationship between Platelet Serotonin Transporter Functionality, Depression, and Fatigue in Patients with Untreated Chronic Hepatitis C
Abstract
Objective and Methods. Although the interaction between fatigue and depression in patients with chronic hepatitis C infection (HCV) has been recognized, the biological correlates of this observation have yet to be reported. We addressed this issue by examining serotonin transporter- (SERT-) driven [(14)C]-serotonin uptake rate (SUR) and serotonin content in platelets of 65 untreated HCV patients and 65 healthy control subjects (HCS). All patients completed report questionnaires for fatigue, depression, and general psychopathology. Structured interviews were conducted by a board-certified psychiatrist. Results. Whereas 36 of the patients experienced fatigue of moderate-to-severe intensity, only 16 reported symptoms of depression (BDI score > 10). Mean SUR in patients with depressive symptoms was significantly higher relative to the HCS, corresponding to a large Cohen's effect size of d = 1.45 (95% CI = 0.66-1.83). Patients who rated their fatigue to have a marked impact on mood and activity displayed a moderate relationship between the BDI score and SUR (n = 18, r = 0.563, P = 0.015), which becomes stronger after controlling for age, gender, and thrombocytopenia (r part = 0.710, P = 0.003). In the univariate analysis, high fatigue interference score, thrombocytopenia, and high SUR were all significant predictors of depression. Conclusions. High SERT activity could be implicated in the expression of depressive symptoms especially in a subgroup of HCV patients who are feeling fatigue as markedly distressing.
Figures




Similar articles
-
[Hepatitis C, interferon a and depression: main physiopathologic hypothesis].Encephale. 2005 May-Jun;31(3):349-57. doi: 10.1016/s0013-7006(05)82400-5. Encephale. 2005. PMID: 16142050 Review. French.
-
Antidepressant effects of direct-acting antivirals against hepatitis C virus-Results from a pilot study.Eur J Clin Invest. 2018 Dec;48(12):e13024. doi: 10.1111/eci.13024. Epub 2018 Sep 19. Eur J Clin Invest. 2018. PMID: 30175442
-
[Depressive symptoms during treatment with interferon alpha for HCV infection--preliminary report].Psychiatr Pol. 2006 Jul-Aug;40(4):799-808. Psychiatr Pol. 2006. PMID: 17068951 Polish.
-
Fatigue and depressive symptoms associated with chronic viral hepatitis patients. health-related quality of life (HRQOL).Ann Hepatol. 2010 Oct-Dec;9(4):419-27. Ann Hepatol. 2010. PMID: 21057161
-
Depression, fatigue and neurocognitive deficits in chronic hepatitis C.Hepatol Int. 2018 Jul;12(4):294-304. doi: 10.1007/s12072-018-9879-5. Epub 2018 Jun 21. Hepatol Int. 2018. PMID: 29931590 Review.
Cited by
-
A Survey on the Prevalence of Depression in Blood Donors with Hepatitis C in Shiraz.Hepat Mon. 2016 Nov 6;16(11):e31080. doi: 10.5812/hepatmon.31080. eCollection 2016 Nov. Hepat Mon. 2016. PMID: 28070197 Free PMC article.
-
Biomarkers of Affective Dysregulation Associated with In Utero Exposure to EtOH.Cells. 2023 Dec 19;13(1):2. doi: 10.3390/cells13010002. Cells. 2023. PMID: 38201206 Free PMC article.
-
Frequency of and Risk Factors for Depression among Participants in the Swiss HIV Cohort Study (SHCS).PLoS One. 2015 Oct 22;10(10):e0140943. doi: 10.1371/journal.pone.0140943. eCollection 2015. PLoS One. 2015. PMID: 26492488 Free PMC article.
References
-
- Johnson ME, Fisher DG, Fenaughty A, Theno SA. Hepatitis C virus and depression in drug users. American Journal of Gastroenterology. 1998;93(5):785–789. - PubMed
-
- Leutscher PDC, Lagging M, Buhl MR, et al. Evaluation of depression as a risk factor for treatment failure in chronic hepatitis C. Hepatology. 2010;52(2):430–435. - PubMed
-
- Dwight MM, Kowdley KV, Russo JE, Ciechanowski PS, Larson AM, Katon WJ. Depression, fatigue, and functional disability in patients with chronic hepatitis C. Journal of Psychosomatic Research. 2000;49(5):311–317. - PubMed
-
- Kraus MR, Schafer A, Csef H, Scheurlen M, Faller H. Emotional state, coping styles, and somatic variables in patients with chronic hepatitis C. Psychosomatics. 2000;41(5):377–384. - PubMed
LinkOut - more resources
Full Text Sources
Other Literature Sources